Aktis Oncology is a clinical-stage biotechnology company developing next-generation precision radiopharmaceuticals for the treatment of cancer. The company has built a proprietary miniprotein radioconjugate platform that pairs tumor-targeting miniproteins with targeted alpha-particle emitters, aiming to reach solid-tumor types that have been… - View it on GitHub